Autopsy report · NCT02675556

Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression

“Difficulty in recruitment and funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 9 months before it started.
• Ran for about 1 year 5 months before it stopped.
• 1 participant enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Joshua M Hare

Sponsor type

University, hospital or other

Conditions

Treatment Resistant Depression

Interventions

Allo-hMSCs; Placebo

Participants

1

Sites

1

Countries

United States

Trials that died the same way

• Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)
  “Recruitment and funding challenges” (88% match in meaning)
• Effect of Antibiotics on Urinary Microbiome
  “funding , recruitment issues” (88% match in meaning)
• Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
  “insufficient funding and recruitment” (87% match in meaning)
• Efficacy of Angiographic Embolization vs Non-embolization of Moderate/Poor Vascularized Vertebral Metastases on Intraoperative Bleeding During Surgery Decompression and Vertebral Stabilization.
  “Difficulties in recruitment.” (86% match in meaning)
• Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen
  “Difficulty with recruitment.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.